• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks

    Healthcare-related ETFs May Benefit Investors

    Written by Charlotte McLeod
    |
    Sep. 19, 2014 11:45AM PST

    ETF Trends reported that investors looking to expand their portfolios might look to healthcare-related exchange-traded funds, which can “benefit from an aging demographic, expanding services and innovative products.”

    ETF Trends reported that investors looking to expand their portfolios might look to healthcare-related exchange-traded funds, which can “benefit from an aging demographic, expanding services and innovative products.”

    As quoted in the market news:

    The healthcare sector has been among the best performing sectors so far this year. Year-to-date, the Health Care Select Sector SPDR (NYSEArca: XLV) gained 17.3% andVanguard Health Care ETF (NYSEArca:VHT) rose 16.8%.

    With the sweeping changes in the healthcare system and rising employment, more people will have health care coverage, and Robert Goldsborough, manager, research analyst and ETF specialist with Morningstar, argues that healthcare ETFs like XLV and VHT are cost-efficient ways to access the growth, reports Joanne Cleaver for U.S. News.

    Investors, though, should refrain from trying to time the market as the traditionally defensive sector is less likely to experience a major correction. ‘This is not a bargain-hunting situation,’ Goldsborough added.

    Click here to read the full ETF Trends report.

    The Conversation (0)

    Go Deeper

    AI Powered

    Browse Topics

    Blank pill bottle spilling a variety of pharmaceutical pills and capsules.

    5 Biggest Pharmaceutical ETFs for Investors in 2026

    Latest News

    Lexaria Enters a New Pharmaceutical Agreement for DehydraTECH

    BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026 

    Appendix 4C Cashflow Statementand Quarterly Activities Report

    More News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Life Science Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES